This engagement will be among the first in the nation to combine the latest digital imaging technologies, computational image analysis and big data.
Tampa, FL (PRWEB) July 05, 2016
Cancer diagnostics and digital pathology workflow solution provider Inspirata, Inc. today announced it has been selected to provide a comprehensive and long-term digital pathology workflow solution at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James) and the Department for Pathology located at The Ohio State University Wexner Medical Center in Columbus, Ohio. The solution Inspirata will create for the OSUCCC – James combines whole slide imaging (WSI) with viewing software and imaging analytics within an integrated system (cockpit) that uses sophisticated algorithms.
The scope of the engagement spans all of the hardware, software and services necessary to support a fully automated end-to-end pathology workflow solution. This includes deploying a bank of Philips Ultra-Fast Scanners (UFS) and IMS, as well as EMC converged infrastructure and providing the staffing needed to digitize the institution’s retrospective and prospective glass pathology slides. It also includes installing Inspirata’s specially designed Digital Pathology Cockpits, a desktop system that will enable the institution’s pathologists to comprehensively review cases; view digitized histology slides and other diagnostic images; share pathology and radiology images for second opinions; and report their findings to treating physicians—all from within the single sign-on, encrypted device. Inspirata’s cockpits will be designed to be fully compatible with the relevant clinical systems of the OSUCCC – James so pathologists can easily access comprehensive information about the patient’s previous diagnostic testing and results.
“The solution that Inspirata is implementing at the OSUCCC-James will enable them to incrementally transform their cancer detection and diagnostic processes from being anchored in the analog world to being opened to the broad spectrum of advantages afforded by the digital world,” says Inspirata Chairman and CEO Satish Sanan. “Through this initiative, the medical center will gain digital access to a wealth of previously unmined data, which is currently stored statically on its retrospective glass slides; streamline the pathology workflow; and strengthen ties with its local and regional affiliates while extending its reach globally using the telemedicine capabilities offered within the cockpit. Finally, our Enterprise Service Bus (ESB) will be used to seamlessly connect the cockpit to other health information and diagnostic systems within the OSUCCC – James, solving interoperability issues and enabling pathologists to be more connected to important information about the patient’s diagnostic history so they can make better-informed decisions.
“This engagement will be among the first in the nation to combine the latest digital imaging technologies, computational image analysis and big data,” continues Sanan. “The vision is to streamline how pathologists review cases enabling them to contribute valuable therapy- and prognosis-related insights to eventually better inform the diagnosis and subsequent care plans for patients.”
“We are excited to partner with Inspirata to implement a digital pathology workflow that aligns with our strategic goals of advancing cancer research and care to help us achieve our vision of creating a cancer-free world,” says Chief Operating Officer of the OSUCCC – James, Jeff Walker.
About the OSUCCC – James
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute strives to create a cancer-free world by integrating scientific research with excellence in education and patient-centered care, a strategy that leads to better methods of prevention, detection and treatment. Ohio State is one of only 45 National Cancer Institute-designated Comprehensive Cancer Centers and one of only four centers funded by the NCI to conduct both phase I and phase II clinical trials on novel anticancer drugs. As the cancer programs 306-bed adult patient-care component, The James is one of the top cancer hospitals in the nation as ranked by U.S. News & World Report and has achieved Magnet designation, the highest honor an organization can receive for quality patient care and professional nursing practice. At 21 floors with more than 1.1 million square feet, The James is a transformational facility that fosters collaboration and integration of cancer research and clinical cancer care. For more information, visit https://cancer.osu.edu/.
About Inspirata, Inc.
Inspirata, Inc. provides a cancer diagnostics solution that digitizes and automates the entire pathology workflow using a unique, “solution as a service” delivery model. This comprehensive solution includes an Enterprise Service Bus (ESB) to solve interoperability issues, and workflow automation and diagnostic tools to help pathologists work more efficiently. Inspirata’s solution also includes a suite of algorithms to extract relevant image-based information from digitized histology specimens for use as supplemental screening tools to assist pathologists with cancer detection and to aid in the prediction of disease progression and therapeutic responses. For more information, please visit http://www.inspirata.com or contact info(at)inspirata(dot)com.